Our Patients Are Now Adults: Do We Have To Worry About Cancer? - Denis Hadjiliadis, MD, MHS

Dr. Denis Hadjiliadis, Director of the Adult CF Program at the University of Pennsylvania and an Associate Professor at the Perelman School of Medicine, provides valuable insight into cancer risk in the CF community. He gives on overview of the most prevalent types of cancer and what screenings should be considered.This presentation was part of CFRI's Virtual 33rd National CF Education Conference on August 2, 2020. CFRI's 33rd National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.